1-[(3,4-DICHLOROPHENYL)MEHYL]-4-(ISOPROPYLOXY)-2,1,3-BENZOTHIADIAZINE-2,2-DIOXIDE
Compound with spectra: 1 NMR
![1-[(3,4-DICHLOROPHENYL)MEHYL]-4-(ISOPROPYLOXY)-2,1,3-BENZOTHIADIAZINE-2,2-DIOXIDE](/api/compound/5wkB14nInT4.png?ph=true&h=300&w=458 "1-[(3,4-DICHLOROPHENYL)MEHYL]-4-(ISOPROPYLOXY)-2,1,3-BENZOTHIADIAZINE-2,2-DIOXIDE")
| SpectraBase Compound ID | 5wkB14nInT4 |
|---|---|
| InChI | InChI=1S/C17H16Cl2N2O3S/c1-11(2)24-17-13-5-3-4-6-16(13)21(25(22,23)20-17)10-12-7-8-14(18)15(19)9-12/h3-9,11H,10H2,1-2H3 |
| InChIKey | UUXPXFJSKFAEJO-UHFFFAOYSA-N |
| Mol Weight | 399.29 g/mol |
| Molecular Formula | C17H16Cl2N2O3S |
| Exact Mass | 398.025869 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1-[(3,4-DICHLOROPHENYL)MEHYL]-4(ETHYLOXY)-2,1,3-BENZOTHIADIAZINE-2,2-DIOXIDE
1-(4-Biphenylylmethyl)-4-(4-biphenylylmethoxy)-2,1,3-benzothiadiazine 2,2-dioxide
Anthranilic acid, N-(p-tolylsulfonyl)-N-veratryl-, methyl ester
1-[(4-CHLOROPHENYL)METHYL]-3-PROPYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE
1-BENZYL-3-ISOPROPYL-1H-2,1,3-BENZOTHIADIAZIN-(4)-3H-ONE 2,2-DIOXIDE
1-[(4-CHLOROPHENYL)METHYL]-3-ETHYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE
N-(TRIFLUOROMETHANESULFONYL)-5,6-DIHYDROPHENANTHRIDINE
2-Methyl-1-(4-methylphenyl)sulfonyl-N-(phenylmethyl)-2,3-dihydroindole-5-sulfonamide
1-(4-fluorophenyl)-2-(3-methoxyphenyl)-4-quinolone
17,17,18,18-tetradehydro-8-nitro-1,10-bis(p-tolylsulphonyl)-1,10-diaza[2](1,3)benzeno[2](1,2)benzeno[2](1,2)benzenophane
| Title | Journal or Book | Year |
|---|---|---|
| Benzothiadiazine dioxides (BTD) derivatives as non-nucleoside human cytomegalovirus (HCMV) inhibitors. study of structural requirements for biological activity☆ | Bioorganic & Medicinal Chemistry | 2003 |